SCHEMBL2391805

SCHEMBL2391805

CCc1c(C=CC(=O)O)cc(Cl)c(-c2ccc(O)c(C34CC5CC(CC(C5)C3)C4)c2)c1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 8/20 0.58
NR0B2 Q15466 3/20 0.58
RARB P10826 6/20 0.57
HDAC11 Q96DB2 3/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
RARA P10276 5/20 0.43
RARG P13631 4/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2391091 0.87 PTPN11 (0.65) PTPN11NR0B2RARBHDAC11HDAC3
SCHEMBL2393700 0.86 PTPN11 (0.57) PTPN11NR0B2RARBHDAC11HDAC3
SCHEMBL2390173 0.85 RARB (0.62) PTPN11NR0B2RARBHDAC11HDAC3
SCHEMBL2391839 0.85 PTPN11 (0.54) PTPN11NR0B2RARBHDAC11HDAC3
SCHEMBL2390148 0.84 RARB (0.58) PTPN11NR0B2RARBHDAC11HDAC3
SCHEMBL2391144 0.84 PTPN11 (0.64) PTPN11NR0B2RARBHDAC11HDAC3
SCHEMBL2394228 0.84 HDAC11 (0.47) PTPN11NR0B2RARBHDAC11HDAC7
SCHEMBL2392376 0.82 RARB (0.58) PTPN11NR0B2RARBHDAC11HDAC3
SCHEMBL2405402 0.81 PTPN11 (0.77) PTPN11NR0B2RARBHDAC11HDAC3
SCHEMBL2405401 0.81 PTPN11 (0.77) PTPN11NR0B2RARBHDAC11HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE42700-E1 Induction of apoptosis in cancer cells SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2011-09-13 US disclosed